Vaccine still a obstacle for Bangladesh, many others: Dr Friedman

Bangladesh
Vaccine still a obstacle for Bangladesh, many others: Dr Friedman
As the environment awaits a Covid-19 vaccine, a US public health expert says a large proportion of people in Bangladesh and other parts of the community must wait a little longer than expected due to limited global capacity of vaccine production. 

"It does take period for the vaccine production to have a level where one can see a real impact," Region Director of Centres for Disease Control and Avoidance (CDC) Dr Michael Friedman told UNB within an interview.

He said a large proportion of people have to wait some time - a long even while, which he says, is a little bit unfortunate but that the reality of the world. 

Dr Friedman, having a good different 27 years of do the job experience in the US and the global stage, said vaccine is now very interesting globally, and three vaccines are showing incredibly positive results. 

"This is exciting reports for the world. Regrettably, I still assume that it is going to remember to get more than enough vaccines in the 1st six months to really change lives," he said.

Vaccine still a obstacle for Bangladesh, numerous others: Dr Friedman

Dr Friedman said this is true for various parts of the community, including Bangladesh, since it takes time to build up capacity. 

The existing world population is just about 7.8 billion and over 15 billion will of vaccines are had a need to address it globally. 

The US expert said only 7 percent people of the world will be covered in the first six months taking into consideration the production capacity of three promising vaccines. 

"So, we’ve to end up being very realistic in this article that a large proportion of people may have to await a year. It may be more than a yr," he said, adding that he sees a genuine challenge for Bangladesh.

Dr Friedman hinted that the majority of the vaccines will go to USA and Europe as there are issue of prepaid (to purchase vaccines) plus they are investigating in the vaccine producing companies to get vaccines on priority basis. 

He also said many countries might show their high an infection rates of coronavirus while the reason. "So, in the initial six months, it will not be easy for many countries to get more than enough vaccines."

The US expert said producing one’s own capacity and carrying out collaboration is the greatest way to get enough vaccines.

"I think Bangladesh is wanting to take action but it’ll remember to develop such capability. This is a very technical process having technical issues," he said. 

Dr Friedman also talked about priorities and who should get primary doses. 

He recommended that most high risk people- health workers, imperative security forces, perhaps essential decision makers found in the federal government and the vulnerable groups should get vaccines on priority basis. 

The government has recently signed a memorandum of understanding (MoU) with the Serum Institute of India (SII) to accumulate three crore shots of Covishield, the Indian version of Oxford-AtraZeneca's coronavirus vaccine.

Overall health Secretary Abdul Mannan hoped that Coronavirus vaccine will be accessible in Bangladesh by February 2021.

Bangladesh features highlighted the need to make the Covid-19 vaccines obtainable, affordable and distributing those equitably to all or any countries that need those most.

A strong global dedication and collaboration to take care of Covid-19 vaccine as a 'global public good' is completely essential, Bangladesh says.

Unicef has begun laying the groundwork for the rapid, safe and efficient delivery of the eventual vaccine by getting and pre-positioning syringes and different necessary equipment.

The moment Covid-19 vaccines successfully emerge from trials and are licensed and recommended for use, the world will require as much syringes as dosages of vaccine. 

To begin preparations, this season, Unicef will stockpile 520 million syringes in its warehouses, portion of a more substantial plan of just one 1 billion syringes by 2021, to ensure initial source and help make certain that syringes get to countries before the Covid-19 vaccines.

During 2021, assuming there are enough doses of Covid-19 vaccines, Unicef anticipates delivering above 1 billion syringes to support Covid-19 vaccination efforts along with the 620 million syringes that Unicef will order for other vaccination programmes against various other diseases such as for example measles, typhoid and even more.

"Vaccinating the environment against Covid-19 will be among the largest mass undertakings in history, and we’ll have to move as quickly seeing that the vaccines can be produced," stated Henrietta Fore, Unicef Executive Director. 

"So that you can move fast afterwards, we must move fast today. By the end of the year, we'll curently have over half of a billion syringes pre-positioned where they can be deployed quickly and expense effectively. That’s enough [syringes] to wrap around the world one and a half times."

In Bangladesh, 35 persons died of Covid-19 within the last a day till 8:00am Thursday, according to the Directorate Basic of Overall health Services (DGHS).

The full total number of deaths reached 6,748 showing 1.43 percent death rate.

The total number of infected people has ended 471,739.
Tags :
Share This News On: